Literature DB >> 5576004

Effects of oral contraceptives on human plasma vitamin-A levels.

I Gal, C Parkinson, I Craft.   

Abstract

Vitamin-A levels have been determined in healthy non-pregnant women and in women taking synthetic steroids to suppress ovulation. A significant increase has been found in those receiving oral contraceptives. Further work is necessary to determine whether this may affect the fetus in patients who become pregnant shortly after discontinuing oral contraception.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576004      PMCID: PMC1796170          DOI: 10.1136/bmj.2.5759.436

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Changes in serum vitamin A level during the human menstrual cycle.

Authors:  P A LAURENCE; A E SOBEL
Journal:  J Clin Endocrinol Metab       Date:  1953-10       Impact factor: 5.958

2.  Estimation of vitamin A and carotene in human blood.

Authors:  S Yudkin
Journal:  Biochem J       Date:  1941-04       Impact factor: 3.857

3.  Reexamination of enzyme activities thought to show evidence of a coenzyme role for vitamin A.

Authors:  W E Rogers
Journal:  Am J Clin Nutr       Date:  1969-08       Impact factor: 7.045

4.  Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins.

Authors:  C B Laurell; S Kullander; J Thorell
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

5.  Oral contraceptives and blood-iron.

Authors:  M Briggs; M Staniford
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

6.  Hormonal pregnancy tests and congenital malformation.

Authors:  I Gal; B Kirman; J Stern
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

7.  Folate deficiency and oral contraceptives.

Authors:  R R Streiff
Journal:  JAMA       Date:  1970-10-05       Impact factor: 56.272

8.  Retinol transport in human plasma.

Authors:  D S Goodman
Journal:  Am J Clin Nutr       Date:  1969-07       Impact factor: 7.045

9.  Plasma insulin and blood glucose levels in patients taking oral contraceptives. A preliminary report of a prospective study.

Authors:  W N Spellacy; K L Carlson
Journal:  Am J Obstet Gynecol       Date:  1966-06-15       Impact factor: 8.661

10.  Effect of vitamin A on enzymic conversion of the delta-5-3-beta-hydroxy- into delta-4-3-oxosteroids by adrenals of the rat.

Authors:  R Grangaud; M Nicol; D Desplanques
Journal:  Am J Clin Nutr       Date:  1969-08       Impact factor: 7.045

View more
  11 in total

1.  Hormonal pregnancy tests and congenital malformations.

Authors:  I Gal
Journal:  Br Med J       Date:  1977-05-28

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 3.  [Metabolic studies under administration of oral contraceptives. A review].

Authors:  S Hauschildt
Journal:  Z Ernahrungswiss       Date:  1978-03

4.  Possible mechanisms of human teratogenesis by imperfect potato.

Authors:  I Gal
Journal:  Humangenetik       Date:  1973-09-20

5.  Letter: Vitamin A, pregnancy, and oral contraceptives.

Authors:  I Gal
Journal:  Br Med J       Date:  1974-06-08

6.  Letter: Vitamin A and the teratogenic risks of oral contraceptives.

Authors:  M H Briggs
Journal:  Br Med J       Date:  1974-07-20

7.  A selected public health bibliography with annotations.

Authors:  C M Wylie
Journal:  Am J Public Health       Date:  1971-09       Impact factor: 9.308

8.  Hormonal regulation of retinoic acid-binding proteins in the mammary gland.

Authors:  R G Mehta; R C Moon
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

9.  Vitamin A, pregnancy, and oral contraceptives.

Authors:  J Wild; C J Schorah; R W Smithells
Journal:  Br Med J       Date:  1974-01-12

10.  Cancer of the cervix uteri and vitamin A.

Authors:  R W Harris; D Forman; R Doll; M P Vessey; N J Wald
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.